There is no clear evidence to demonstrate the effectiveness of hyperbaric oxygen therapy in the treatment of malignant otitis externa
Malignant otitis externa is an uncommon, although potentially fatal, infection of the external ear canal including the surrounding soft tissue and bone. It is mainly found in the elderly or diabetics. Treatments include antibiotics, stringent diabetes control, the repeated removal of dead tissue and surgical management. Hyperbaric oxygen therapy is increasingly being used in addition to these treatments where facilities exist. The review found no trials to demonstrate that the addition of hyperbaric oxygen therapy offers a better outcome than the treatments alone. Further research is required.
This version first published online:
April 20. 2005
Abstract
Background
Malignant, or necrotising, otitis externa is a potentially fatal infection of the external ear canal and surrounding soft tissue and bone. It may be complicated by involvement of cranial nerves, principally the facial nerves and the contents of the jugular foramen. It is an uncommon condition mainly found in the elderly or in diabetics.
Objectives
To assess the effectiveness of adjunctive hyperbaric oxygen treatment for malignant otitis externa.
Search strategy
We searched the Cochrane Central Register of Controlled Trials (CENTRAL) (The Cochrane Library Issue 2, 2006), MEDLINE (January 1966 to June 2006) and EMBASE (January 1985 to June 2006) with pre-specified terms. The date of the last search was 28th June 2006.
No identified articles described randomised controlled trials of hyperbaric oxygen therapy in the treatment of malignant otitis externa.
Main results
Due to the lack of data no results could be presented.
Authors' conclusions
No clear evidence exists to demonstrate the efficacy of hyperbaric oxygen therapy when compared to treatment with antibiotics and/or surgery. No data were found to compare rates of complication between the different treatment modalities. Further research is required.